A self-assembling peptide hydrogel delivered immune-guiding signals in two phases, steering macrophages toward tissue repair rather than inflammation and fully dissolving within 14 days.
14-day resorptioninjectable peptide hydrogel recruited healing macrophages within 3 days and completely dissolved by 2 weeks — no permanent implant needed
What the researchers found
A self-assembling multidomain peptide hydrogel delivered cytokines in a biphasic pattern that controlled immune cell behavior in both space and time. The nanofibrous scaffold recruited monocytes and macrophages, promoted their polarization toward a healing (M2) phenotype without creating inflammation, and was completely resorbed within 14 days of subcutaneous implantation. The injectable material recovered after shear stress, making it suitable for injection-based delivery.
Why it matters
Controlling the immune response at a wound or implant site is crucial for healing. This peptide hydrogel achieves something difficult — recruiting immune cells and guiding them toward repair rather than inflammation — using a fully synthetic, injectable, and biodegradable peptide material. It demonstrates the potential of designed peptides as programmable biomaterials.
The numbers in context
Biphasic cytokine release · macrophage infiltration by day 3 · complete scaffold resorption by day 14 · M2 pro-resolution environment · injectable with shear recovery
How the study worked
Multidomain peptides were synthesized and self-assembled into nanofibrous hydrogels loaded with cytokines. In vitro, THP-1 monocyte/macrophage activation and polarization were assessed. In vivo, scaffolds were injected subcutaneously in Wistar rats and evaluated for macrophage infiltration, polarization, and scaffold degradation at multiple time points up to 14 days.
Who was studied
In vitro THP-1 monocyte/macrophage cultures and in vivo subcutaneous implantation in Wistar rats
What this study cannot tell us
Subcutaneous implantation is a simplified model — actual tissue engineering applications (bone, cartilage, etc.) present different challenges. Specific cytokines used and quantitative release kinetics are not detailed in the abstract. Long-term outcomes beyond 14 days (actual tissue regeneration) were not assessed. Only one animal model was used.
How to read the evidence
This is a preclinical biomaterials study with both in vitro immune cell characterization and in vivo subcutaneous implantation in rats. It provides strong proof of concept for the peptide scaffold platform but represents early-stage evidence requiring testing in disease-specific tissue engineering models.
When this study was published
Published in 2015, this was an influential early study in self-assembling peptide biomaterials. The multidomain peptide platform has since been further developed for various tissue engineering applications by the Hartgerink laboratory.
The bigger picture
Peptide-based biomaterials are emerging as programmable, biocompatible alternatives to synthetic polymers for tissue engineering. This work demonstrates that peptides can be designed not just as drugs but as smart materials that orchestrate complex biological responses. The ability to control immune cell behavior through material design has implications for wound healing, organ repair, and reducing implant rejection.
Questions still open
- Can this peptide hydrogel platform be adapted to deliver different cytokine combinations for specific tissue types (bone, cartilage, nerve)?
- Would the biphasic release pattern maintain its effectiveness in larger, more clinically relevant wound models?
- Could this approach be combined with stem cell delivery to create a complete injectable tissue engineering system?
Common questions
How do peptides self-assemble into a gel?
What does it mean for macrophages to be in 'healing mode' vs 'inflammatory mode'?
Read the original research
Self-assembling multidomain peptides tailor biological responses through biphasic release.
Biomaterials, 52, 71-8
Citation
Kumar, Vivek A; Taylor, Nichole L; Shi, Siyu; Wickremasinghe, Navindee C; D'Souza, Rena N; Hartgerink, Jeffrey D. (2015). Self-assembling multidomain peptides tailor biological responses through biphasic release.. Biomaterials, 52, 71-8. https://doi.org/10.1016/j.biomaterials.2015.01.079